Search Results 1241-1250 of 18868 for Fungus

1. A Study to Evaluate the Safety and Effectiveness of Lisocatagene Maraleucel in Patients - Mayo Clinic

   Subject has uncontrolled systemic fungal, bacterial, viral or other infection despite appropriate antibiotics or other treatment at the time of nonconforming ...

2. A Study Using VE303 to Prevent Recurrence of Clostridium Difficile Infection - Mayo Clinic

   Prior administration of genetically modified investigational live bacterial/fungal/bacteriophage/viral isolates for CDI-associated diarrhea (Exception ...

3. A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial To Demonstrate The Efficacy And Safety Of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered Via The PARI Investigational EFlow® Device Plus Standard Of Care Versus Standard Of Care Alone In The Treatment Of Chronic Lung Allograft Syndrome / Bronchiolitis Obliterans Syndrome In Patients Post Double Lung Transplantation (BOSTON-2) - Mayo Clinic

   Active acute bacterial, viral, or fungal infection not successfully resolved at least 4 weeks prior to the Screening Visit. Patients with chronic infection ...

4. A Study to Evaluate Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma - Mayo Clinic

   Active bacterial, fungal, or viral infections, including hepatitis A, B, and C. Receipt of a live vaccine within 28 days of planned start of study therapy ...

5. A Study of OX40L As a Functional Biomarker for Liver Fibrosis - Mayo Clinic

   Subjects who have a current acute viral, bacterial, or fungal infection. Subjects diagnosed with the Human Immunodeficiency Virus (HIV), or who have tested ...

6. Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19 (enrollment by invitation only) - Mayo Clinic

   Known active tuberculosis (TB), history of incompletely treated TB, suspected or known extrapulmonary TB, suspected or known systemic bacterial or fungal ...

7. A Study to Compare Model Predictive Control (MPC) Artificial Pancreas vs. Sensor Augmented Pump (SAP)/Predictive Low Glucose Suspend (PLGS) with Different Stress Assessments for Type 1 Diabetes Patients - Mayo Clinic

   Systemic fungal infections;; Active infection of any kind, or at risk of infection (susceptibility to infection) from known immunosuppression or underlying ...

8. A Study to Evaluate CTX110 in Subjects with Relapsed or Refractory B-Cell Malignancies - Mayo Clinic

   Presence of bacterial, viral, or fungal infection that is uncontrolled or requires IV anti-infectives. 6. Active HIV, hepatitis B virus or hepatitis C virus ...

9. Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease (BMT CTN 1301) - Mayo Clinic

   Patients with uncontrolled bacterial, viral or fungal infections (currently taking medication and with progression or no clinical improvement) at time of ...

10. Mycobacterium Avium Complex Pulmonary Infections Systems Biology to Predict Progression and Treatment - Mayo Clinic

    Patients diagnosed with concomitant severe pulmonary infection with other pathogen(s) including bacterial empyema or fungal infections. Refractory cough ...